Format

Send to:

Choose Destination
See comment in PubMed Commons below
Korean J Pediatr. 2011 Feb;54(2):90-3. doi: 10.3345/kjp.2011.54.2.90. Epub 2011 Feb 28.

A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.

Author information

  • 1Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.

Abstract

Pseudohypoaldosteronism type 1 (PHA1) is a rare form of mineralocorticoid resistance characterized in newborns by salt wasting with dehydration, hyperkalemia and failure to thrive. This disease is heterogeneous in etiology and includes autosomal dominant PHA1 owing to mutations of the NR3C2 gene encoding the mineralocorticoid receptor, autosomal recessive PHA1 due to mutations of the epithelial sodium channel (ENaC) gene, and secondary PHA1 associated with urinary tract diseases. Amongst these diseases, autosomal dominant PHA1 shows has manifestations restricted to renal tubules including a mild salt loss during infancy and that shows a gradual improvement with advancing age. Here, we report a neonatal case of PHA1 with a NR3C2 gene mutation (a heterozygous c.2146_2147insG in exon 5), in which the patient showed failure to thrive, hyponatremia, hyperkalemia, and elevated plasma renin and aldosterone levels. This is the first case of pseudohypoaldosteronism type 1 confirmed by genetic analysis in Korea.

KEYWORDS:

Infant; Mineralocorticoid; NR3C2 gene; Pseudohypoaldosteronism; Receptor

PMID:
21503203
[PubMed]
PMCID:
PMC3077507
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for The Korean Pediatric Society Icon for PubMed Central
    Loading ...
    Write to the Help Desk